Cengild Medical Berhad (KLSE:CENGILD)

Market Cap	170.75M -21.2%
Revenue (ttm)	74.93M -0.6%
Net Income	9.69M -15.8%
EPS	0.01 -15.8%
Shares Out	832.91M
PE Ratio	15.35
Forward PE	n/a
Dividend	0.01 (4.62%)
Ex-Dividend Date	Feb 25, 2026

Volume	36,500
Average Volume	434,010
Open	0.2050
Previous Close	0.2100
Day's Range	0.2050 - 0.2100
52-Week Range	0.2000 - 0.2750
Beta	0.06
RSI	42.86
Earnings Date	May 28, 2026

About Cengild Medical Berhad

Cengild Medical Berhad, an investment holding company, operates a medical center in Malaysia. The company offers various care and treatment consultant services for gastrointestinal and liver diseases, morbid obesity, and oncology and urological conditions; general cardiology and gynecology assessment; gastroenterology and hepatology; anesthesiology, general surgery, internal medicine, and radiology; ear, nose and throat; gastrointestinal surgeries, including upper gastrointestinal, hepatobiliary, pancreatic, colorectal surgery, and bariatric su...

• Industry: Health Services
• Founded: 2017
• Employees: 151
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: CENGILD

Financial Performance

In fiscal year 2025, Cengild Medical Berhad's revenue was 80.00 million, an increase of 19.72% compared to the previous year's 66.82 million. Earnings were 11.06 million, a decrease of -0.19%.